Polar Capital Holdings Plc 13D and 13G filings for Avadel Pharmaceuticals plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 5:58 pm Sale |
2024-09-30 | 13G | Avadel Pharmaceuticals plc AVDL |
Polar Capital Holdings Plc | 4,803,899 4.990% |
-1,947,883 (-28.85%) |
Filing |
| 2024-02-13 09:40 am Purchase |
2023-12-31 | 13G | Avadel Pharmaceuticals plc AVDL |
Polar Capital Holdings Plc | 6,751,782 7.510% |
3,957,109 (+141.59%) |
Filing |
| 2022-02-14 10:40 am Sale |
2021-12-31 | 13G | Avadel Pharmaceuticals plc AVDL |
Polar Capital Holdings Plc | 2,794,673 4.800% |
-233,032 (-7.70%) |
Filing |
| 2021-02-16 07:32 am Purchase |
2020-12-31 | 13G | Avadel Pharmaceuticals plc AVDL |
Polar Capital Holdings Plc | 3,027,705 5.200% |
3,027,705 (New Position) |
Filing |